<DOC>
	<DOCNO>NCT00046813</DOCNO>
	<brief_summary>The purpose study test use High-Dose versus Regular-Dose Nicotine Patch Nicotine Dependence Individuals Schizophrenia Schizoaffective Disorder</brief_summary>
	<brief_title>Nicotine Patch Nicotine Dependence Individuals With Schizophrenia Schizoaffective Disorder - 1</brief_title>
	<detailed_description>This randomize double-blind placebo control 8 week outpatient medication clinical trial evaluate relative efficacy High-Dose ( 42mg ) versus Regular Dose ( 21mg ) nicotine patch treatment individual schizophrenia schizoaffective disorder nicotine dependence . It also placebo control continuation phase examine long duration treatment effective standard eight week dose schedule . The literature support schizophrenic increase rate smoke likely dependent nicotine . Nicotine gum patch safe approve counter sale United States . High dose patch therapy well tolerate provide complete nicotine replacement . This improve withdrawal symptom relief hypothesize abstinence rate smoke great high dose patch group . Few trial examine usefulness nicotine replacement therapy population preliminary evidence show lower expect success rate smoke cessation conventional treatment</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects : 100 stable outpatient schizophrenia schizoaffective disorder nicotine dependence . All subject meet follow inclusion criterion : Patients able provide inform consent Patients meet DSMIV diagnostic criterion Nicotine Dependence Schizophrenia Schizoaffective disorder Patients stable current antipsychotic regimen interested treatment psychiatric nicotine dependence Potential subject meeting follow criterion exclude : Patients history clinically significant angina unstable angina pectoris Patients severe CAD recent myocardial infarction ( within last 6 month ) Patients evidence history severe medical illness ( hematologic , renal neoplastic ) Patients represent serious suicide risk , include recent suicidal behavior attempt within last thirty day Patients history severe skin allergy chronic dermatosis Concomitant use clonidine bupropion Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>